It mainly covers multiple treatment fields such as cardiovascular disease, diabetes and anti-virus.
Mainly based on peptide APIls, supplemented by small molecule chemical drugs.
Mainly concentrated in the field of diabetes and antiviral, currently in the preclinical research stage.
After many years of accumulation, our company has the ability to undertake various high-tech projects in the field of small molecule chemical drugs and peptides.
Our company provides a one-stop CRO service based on an in-depth understanding of ICH and R & D philosophy of QbD. With professional knowledge and strict standards, we provide customers with (chemical, peptide) pharmaceutical research, clinical services and registration services to meet the needs of customers at different stages of generic drug consistency evaluation and bioequivalence clinical.